BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Jul 23, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-07-13

Reporting Person: Acosta Andrea (GVP, Chief Accounting Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1649	Direct
Common Stock	4380	Direct
Common Stock	1645	Direct
Common Stock	1500	Direct
Common Stock	2535	Direct
Common Stock	3250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy Common Stock)	$73.82	2030-03-15	Common Stock (8320)		Direct
Stock Option (Right to buy Common Stock)	$86.98	2027-07-16	Common Stock (5340)		Direct
Stock Option (Right to buy Common Stock)	$83.57	2028-03-14	Common Stock (4790)		Direct
Stock Option (Right to buy Common Stock)	$94.53	2029-03-14	Common Stock (5630)		Direct

Footnotes

F1: Restricted stock units granted on March 16, 2020. Price not applicable.

F2: Restricted stock units granted on July 17, 2017. Price not applicable.

F3: Restricted stock units granted on March 15, 2018. Price not applicable.

F4: Restricted stock units granted on March 15, 2019. Price not applicable.

F5: Restricted stock units granted on June 29, 2020. Price not applicable.

F6: Option grant vests 12/48th on the date exercisable and 1/48th each month thereafter.